These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 36282294)
21. Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone. Rutkowski P; Ferrari S; Grimer RJ; Stalley PD; Dijkstra SP; Pienkowski A; Vaz G; Wunder JS; Seeger LL; Feng A; Roberts ZJ; Bach BA Ann Surg Oncol; 2015 Sep; 22(9):2860-8. PubMed ID: 26033180 [TBL] [Abstract][Full Text] [Related]
22. Recurrent giant cell tumour of the distal ulna after en bloc resection with preoperative denosumab use. Fujihara N; Hamada S; Yoshida M; Tsukushi S BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764115 [TBL] [Abstract][Full Text] [Related]
23. Giant cell tumour of bone in the denosumab era. van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529 [TBL] [Abstract][Full Text] [Related]
24. Denosumab for Bone Giant Cell Tumor of the Distal Radius. Tsukamoto S; Mavrogenis AF; Tanzi P; Leone G; Ciani G; Righi A; Akahane M; Honoki K; Tanaka Y; Donati DM; Errani C Orthopedics; 2020 Sep; 43(5):284-291. PubMed ID: 32745221 [TBL] [Abstract][Full Text] [Related]
25. Utility of intraoperative magnetic resonance imaging for giant cell tumor of bone after denosumab treatment: a pilot study. Furuta T; Kubo T; Sakuda T; Saito T; Kurisu K; Muragaki Y; Adachi N Acta Radiol; 2022 Feb; 63(2):176-181. PubMed ID: 33517664 [TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone. Puri A; Gulia A; Hegde P; Verma V; Rekhi B Bone Joint J; 2019 Feb; 101-B(2):170-177. PubMed ID: 30700112 [TBL] [Abstract][Full Text] [Related]
28. Denosumab in giant cell tumour of bone in the pelvis and sacrum: Long-term therapy or bone resection? Sambri A; Medellin MR; Errani C; Campanacci L; Fujiwara T; Donati D; Parry M; Grimer R J Orthop Sci; 2020 May; 25(3):513-519. PubMed ID: 31155442 [TBL] [Abstract][Full Text] [Related]
29. Current Concepts in the Treatment of Giant Cell Tumor of Bone: An Update. Tsukamoto S; Mavrogenis AF; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Errani C Curr Oncol; 2024 Apr; 31(4):2112-2132. PubMed ID: 38668060 [TBL] [Abstract][Full Text] [Related]
30. Preoperative denosumab treatment in patients with giant cell bone tumors in limbs: A retrospective study using propensity score matching. Huang Y; Xu M; Wang B; Zhao Z; Lin T; Huang G; Yin J; Xie X; Shen J; Zou C Cancer Med; 2023 Jun; 12(11):12041-12049. PubMed ID: 37212474 [TBL] [Abstract][Full Text] [Related]
31. Denosumab Does Not Decrease Local Recurrence in Giant Cell Tumor of Bone Treated With En Bloc Resection. Tsukamoto S; Mavrogenis AF; Tanaka Y; Kido A; Kawaguchi M; Errani C Orthopedics; 2021; 44(6):326-332. PubMed ID: 34618637 [TBL] [Abstract][Full Text] [Related]
32. Extended curettage versus en bloc resection for the treatment of grade 3 giant cell tumour of the knee with pathologic fracture: a retrospective study. Jamshidi K; Zandrahimi F; Haji Agha Bozorgi M; Arefpour AM; Bagherifard A; Al-Baseesee HH; Mirzaei A Int Orthop; 2021 Jan; 45(1):289-297. PubMed ID: 33001283 [TBL] [Abstract][Full Text] [Related]
33. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius. Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594 [TBL] [Abstract][Full Text] [Related]
34. A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610. Urakawa H; Mizusawa J; Tanaka K; Eba J; Hiraga H; Kawai A; Nishida Y; Hosaka M; Iwamoto Y; Fukuda H; Ozaki T Jpn J Clin Oncol; 2019 Apr; 49(4):379-382. PubMed ID: 30796832 [TBL] [Abstract][Full Text] [Related]
35. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial. Rutkowski P; Gaston L; Borkowska A; Stacchiotti S; Gelderblom H; Baldi GG; Palmerini E; Casali P; Gronchi A; Parry M; Campanacci DA; Scoccianti G; Wagrodzki M; Ferrari S; Dijkstra S; Pieńkowski A; Grimer R Eur J Surg Oncol; 2018 Sep; 44(9):1384-1390. PubMed ID: 29650420 [TBL] [Abstract][Full Text] [Related]
36. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience. Agarwal MG; Gundavda MK; Gupta R; Reddy R Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215 [TBL] [Abstract][Full Text] [Related]
37. Current management of giant-cell tumor of bone in the denosumab era. Nagano A; Urakawa H; Tanaka K; Ozaki T Jpn J Clin Oncol; 2022 May; 52(5):411-416. PubMed ID: 35199172 [TBL] [Abstract][Full Text] [Related]
38. Ultra-Short Course of Neo-Adjuvant Denosumab for Nerve-Sparing Surgery for Giant Cell Tumor of Bone in Sacrum. Liang H; Liu X; Yang Y; Guo W; Yang R; Tang X; Yan T; Li Y; Tang S; Li D; Qu H; Dong S; Ji T; Du Z; Zang J Spine (Phila Pa 1976); 2022 May; 47(9):691-701. PubMed ID: 34961753 [TBL] [Abstract][Full Text] [Related]
39. ASO Author Reflections: Preoperative Denosumab May Increase the Risk of Local Recurrence of Giant Cell Tumor of Bone after Curettage Surgery. Asano N; Horiuchi K Ann Surg Oncol; 2022 Jun; 29(6):4001. PubMed ID: 35169975 [No Abstract] [Full Text] [Related]
40. Novel Strategy of Curettage and Adjuvant Microwave Therapy for the Treatment of Giant Cell Tumor of Bone in Extremities: A Preliminary Study. Ke J; Cheng S; Yao MY; Chu X; Wang M; Zeng XL; Yang T; Zhang C; Zhong H; Zhang Y Orthop Surg; 2021 Feb; 13(1):185-195. PubMed ID: 33442922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]